(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one hydrochloride

• ChemBase编号: 174947
• 分子式: C20H24ClNO4
• 平均质量: 377.86186
• 单一同位素质量: 377.13938593
• SMILES: c1(c2c3c(cc1)C[C@@H]1[C@]4([C@@]3([C@H](C(=O)CC4)O2)CCN1CC1CC1)O)O.Cl
• Canonical SMILES: O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O.Cl
• InChI: InChI=1S/C20H23NO4.ClH/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;/h3-4,11,15,18,22,24H,1-2,5-10H2;1H/t15-,18+,19+,20-;/m1./s1
• InChIKey: RHBRMCOKKKZVRY-ITLPAZOVSA-N

名称和登记号

名称

• IUPAC标准名: (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^1,^1^3.0^5,^1^7.0^7,^1^8]octadeca-7(18),8,10-trien-14-one hydrochloride; (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^1,^1^3.0^5,^1^7.0^7,^1^8]octadeca-7,9,11(18)-trien-14-one hydrochloride
• IUPAC传统名: naltrexone hydrochloride
• 别名: (5α)-17-(Cyclopropyl-methyl-d3)-4,5-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride; Antaxone; Depade; EN 1639A; NIH 8503; Nalorex; Trexan; Naltrexone Hydrochloride; Naltrexone HCl

登记号

• CAS号: 16676-29-2
• PubChem SID: 164230857
• PubChem CID: 5485201

理论计算性质

• 极化表面积: 70.0 Å^2
• 可自由旋转的化学键: 2
• 里宾斯基五规则: true
• Acid pKa: 10.106068
• 质子受体: 5
• 质子供体: 2
• LogD (pH = 5.5): -1.4911842
• LogD (pH = 7.4): 0.13493212
• Log P: 1.3626752
• 摩尔折射率: 91.5015 cm^3
• 极化性: 35.902298 Å^3

分子性质

理化性质

• 溶解度: DMSO; Methanol; Water
• 外观: White to Off- White Solid
• 熔点: 230-232°C

安全信息

• 保存条件: -20°C Freezer

药理学性质

• 作用靶点: Opioid Receptor

产品相关信息

• 成盐信息: HCl

详细说明

Toronto Research Chemicals - N285750

Nonselective opioid receptor antagonist; congener of Naloxone.

参考文献

• Maickel, R.P., et al.: Ann. N.Y. Acad. Sci., 281, 321 (1976)
• Gritz, E.R., et al.: Clin. Pharmacol. Ther. 19, 773 (1976)
• Gonzales, J.P., et al.: Drugs, 35, 192 (1976)
• Berg, B.J., et al.: Drug Saf., 15, 274 (1976)